03 · Product
Relief without
medication.
A discreet wearable that reads the patient's own neurophysiology and delivers precisely-timed stimulation to interrupt migraine onset — no drugs.
Overview
A different theory of migraine.
Migraine isn't a headache — it's a self-reinforcing neurovascular event with clear electrophysiological precursors. Most treatments arrive after the cascade has begun.
Our device listens for the signatures of onset and delivers targeted, non-invasive stimulation to interrupt the cascade before pain sets in.
Interactive
See the attack coming. Stop it before it starts.
Status
Monitoring…
no anomaly detected
Mechanism
A closed loop between the body and the device.
- Step 01
Sense
Low-power biosignal capture tracks the neurophysiological state.
- Step 02
Predict
An on-device model recognizes onset signatures minutes before pain.
- Step 03
Stimulate
A personalized non-invasive waveform interrupts the cascade.
- Step 04
Adapt
Every episode refines the personal model; therapy gets more precise.
Applications
Where drug-free therapy matters most.
Chronic migraine
Reduce monthly migraine days without preventive medication load.
Acute onset
Interrupt episodes on demand — without triptans or opioids.
Pregnancy
Non-pharmacological relief where drug options are severely constrained.
Pediatric care
A pathway for adolescents where long-term drug exposure is a concern.
Science
Neuromodulation, done rigorously.
- MECHANISMInternal, 2025
Closed-loop non-invasive neuromodulation of migraine precursors
- TRIALPlanned, UAE
First-in-human feasibility study
- STANDARDIn progress
IEC 60601, ISO 14971, MDR pathways
- PARTNERMulti-center
Neurology and pain-medicine collaborations
FAQ
Questions patients and clinicians ask.
Is it safe?
Low-intensity, non-invasive stimulation with an extensive safety record. Clinical validation is jurisdiction-by-jurisdiction.
Do I stop my medication?
No — never change treatment without a clinician. The therapy is designed to reduce reliance over time, in partnership with the treating physician.
How is it different from existing devices?
Closed-loop and personalized — stimulation is triggered by the patient's own onset signatures, not a fixed schedule.
When is it available?
Staged by jurisdiction and clinical validation. Register interest via /contact.
Continue exploring
Partnerships
Building in adjacent healthcare, pharma, or neurotech? Let's talk.